Assessing gastro-intestinal related quality of life in cystic fibrosis: Validation of PedsQL GI in children and their parents-Reference-Cited by-同舟云学术

Assessing gastro-intestinal related quality of life in cystic fibrosis: Validation of PedsQL GI in children and their parents

Published:2019-12-20 Issue:12 Volume:14 Page:e0225004
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Boon Mieke^ORCID,Claes Ine,Havermans Trudy,Fornés-Ferrer Victoria,Calvo-Lerma Joaquim^ORCID,Asseiceira Inês,Bulfamante Anna,Garriga María,Masip Etna,Woodcock Sandra^ORCID,Walet Sylvia,Barreto Celeste,Colombo Carla,Crespo Paula,Van der Wiel Els,Hulst Jessie,Martinez-Barona Sandra,Nobili Rita,Pereira Luisa,Ruperto Mar,Vicente Saioa,De Boeck Kris,Ribes-Koninckx Carmen,

Funder

Horizon 2020 Framework Programme

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Orenti A, Zolin A, Naehrlich L, van Rens J et al. ECFSPR Annual Report 2016. https://www.ecfs.eu/sites/default/files/general-content-images/working-groups/ecfs-patient-registry/ECFSPR_Report2016_06062018.pdf

2. European Cystic Fibrosis Society Standards of Care: Best Practice guidelines;AR Smyth;J Cyst Fibros,2014

3. Enzyme replacement therapy for pancreatic insufficiency: present and future;A Fieker;Clin Exp Gastroenterol,2011

4. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry;E Kerem;Eur Respir J,2014

5. Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study;AL Stephenson;Am J Clin Nutr,2013

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Presentation, characteristics and management of obstructive intestinal conditions in cystic fibrosis;Frontline Gastroenterology;2024-01-06

2. Long-term evaluation of faecal calprotectin levels in a European cohort of children with cystic fibrosis;Archives of Disease in Childhood;2023-12-18

3. Gastroenterology services for patients with Cystic Fibrosis across Australia and New Zealand: a multi-stakeholder assessment of patients' and professionals’ perspectives;Frontiers in Pediatrics;2023-12-15

4. Reduction in abdominal symptoms (CFAbd-Score), faecal M2-pyruvate-kinase and Calprotectin over one year of treatment with Elexacaftor-Tezacaftor-Ivacaftor in people with CF aged ≥12 years – The RECOVER study;Journal of Cystic Fibrosis;2023-10

5. Update on Cystic Fibrosis in Pediatric Patients;Current Gastroenterology Reports;2023-09-01